Can a low dose of aspirin every day prevent diseases for seniors?
That's what the largest clinical trial ever undertaken in the country wants to uncover - and now it's got federal government funding for the final stage of its research.
The trial by Monash University's Professor John McNeil has been granted almost $5 million as part of a $483 million funding round for health and medical research.
It involves 16,700 Australians aged 70 and over and 2000 GPs, with the money helping the trial complete data collection to discover the benefits and risks of aspirin.
Health Minister Sussan Ley will on Saturday announce the other funded projects which include one which predicts the progressive phase of multiple sclerosis, the link between Alzheimer's and brain injuries and the health impacts of sleep apnoea in men.
